|
 |
EprosartanThis page contains recent news articles, when available, and an overview of Eprosartan but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Correspondence: Prof. J Cockcroft, Department of Cardiology (JRC), University of Wales College of Medicine, University Hospital, Cardiff CF4 4XN, ... Nature.com Eprosartan (Systemic ). - Oct 27, 2005 Eprosartan (ep-roe-SAR-tan )belongs to the class of medicines called angiotensin II inhibitors. It is used to treat high blood pressure (hypertension). ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Solvay's sourcing from Dishman to cross Rs 100 cr. - Oct 23, 2006 Already, Solvay has increased sourcing of eprosartan, an API used in making anti-hypertensive drug Teveten, by 50 percent after their US foray. ... Free with registration - Economic Times - AccessMyLibrary.com Solvay to outsource Dishman's eprosartan to US - May 11, 2006 Solvay Pharmaceuticals BV, a fortune 500 company, which had been sourcing eprosartan mesylate, an anti hyper-tension drug, manufactured by Dishman ... pharmabiz.com Eprosartan Lowers Blood Pressure, Reduces Risk of New Event After … - Feb 7, 2005 By Cameron Johnston. To date only 3 studies have been done to determine the impact that lowering blood pressure has on events such as strokes, ... DG News … patients, atenolol impacts central systolic BP less than eprosartan... - Mar 28, 2006 Z. Dhakam and colleagues at Cambridge University explained, "The aim of the present study was to compare the hemodynamic effects of atenolol and eprosartan ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Hypoglycemia; Eprosartan does not inhibit sympathetic reactivity in … - Apr 12, 2005 2005 APR 12 - (NewsRx.com) -- Eprosartan (EPRO), an AT(I)-receptor blocker, does not inhibit sympathetic reactivity in humans. ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Glostrup County Hospital; Eprosartan does not inhibit sympathetic … - Apr 13, 2005 2005 APR 13 - (NewsRx.com) -- Eprosartan (EPRO), an AT(I)-receptor blocker, does not inhibit sympathetic reactivity in humans. ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones Teveten HCT.(drug overview)(Drug overview) - Dec 1, 2005 One component, eprosartan, belongs to a class of blood pressure medications that work by ... If you have ever had an allergic reaction to eprosartan, ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com Diabetes Therapy; Researchers detail new studies and findings in the ... - Apr 12, 2005 ..."Telmisartan, but not eprosartan, significantly improved plasma total cholesterol (p<0.01), low-density lipoprotein cholesterol (p<0.01), and triglycerides ... Pay-Per-View - Science Letter - Factiva, from Dow Jones University of Medicine & Dentistry of New; Researchers detail new... - Apr 13, 2005 ..."Telmisartan, but not eprosartan, significantly improved plasma total cholesterol (p<0.01), low-density lipoprotein cholesterol (p<0.01), and triglycerides ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones Diabetes Therapy; Studies advance knowledge in diabetes therapy … - Jul 11, 2005 ..."Telmisartan, but not eprosartan, significantly improved plasma total cholesterol (p<0.01), low-density lipoprotein cholesterol (p<0.01), and triglycerides ... Pay-Per-View - Clinical Trials Week - Factiva, from Dow Jones Diabetes Therapy; Researchers detail new studies and findings in the ... - Apr 16, 2005 ..."Telmisartan, but not eprosartan, significantly improved plasma total cholesterol (p<0.01), low-density lipoprotein cholesterol (p<0.01), and triglycerides ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones Renal Failure; Ang II-independent sympathetic hyperactivity contribute... - Jan 4, 2005 ...[Our] study assessed the effect of chronic eprosartan on BP and sympathetic ... During eprosartan therapy, mean arterial pressure (111±9 to 98±7 mmHg, ... Pay-Per-View - Science Letter - Factiva, from Dow Jones Renal Failure; Ang II-independent sympathetic hyperactivity contribute... - Jan 3, 2005 ...[Our] study assessed the effect of chronic eprosartan on BP and sympathetic ... During eprosartan therapy, mean arterial pressure (111±9 to 98±7 mmHg, ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones The impact of angiotensin II receptor blocker potency on the clinical... - Oct 1, 2007 We used the following Medical Subject Headings (MESH): angiotensin II type I receptor blocker, angiotensin receptor blocker, ARB, candesartan, eprosartan, ... $4.95 - Formulary - ECNext Angiotensin II Antagonists - Therapeutic Benefits Spanning the … - Feb 9, 2006 The search strategy included combining the terms angiotensin II antagonists, angiotensin receptor blockers, losartan, candesartan, eprosartan, irbesartan, ... RedOrbit Help Consumatori - Leggi news - Nov 18, 2005 Tra questi 16 Equivalenti-generici e 2 nuovi farmaci, l'Ossicodone cloridrato e il l'Eprosartan+idroclortiazide. In particolare, l'Ossicodone cloridrato è ... Help Consumatori Issues to consider in the pharmaceutical development of a cardiovascul... - May 14, 2008 50–100 mg for the beta blocker atenolol, to even higher doses in the case of the AT 1 receptor antagonists irbersartan (300 mg) and eprosartan (600 mg). ... Nature.com Heart Failure; Researchers' work adds to heart failure body of... - Dec 20, 2005 ..."Spironolactone (15 mg per g-1 per day-1 ip, via minipump) or eprosartan (5 mg ... "Both spironolactone and eprosartan decreased cardiac mass and collagen ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Highlights of the 30th International Stroke Conference - Feb 28, 2005 The study enrolled a total of 1352 patients (681 eprosartan, 671 nitrendipine) and ... A significant benefit in favor of eprosartan was found in the primary o. Medscape Chemical companies eye pharma pastures - Jan 15, 2006 ...when it signed an agreement with Netherlands-based Solvay Pharmaceuticals for sourcing eprosartan mesylate, an API for Teveten, a hypertensive drug. ... expresspharmapulse.com Kos Enters Cardio Area, Gets Biovail Products For $104M - May 4, 2005 Teveten (eprosartan mesylate) was launched in 1998 by London-based ... Teveten HCT (eprosartan mesylate/hydrochlorothiazide) was launched in 2003 and ... BioWorld Online - BioWorld Online Hypertension Classes of Medications - Hypertension Health Information... - Jul 15, 2008 Losartan (Cozaar, Hyzaar), olmesartan (Benicar) candesartan (Atacand), telmisartan (Micardis), eprosartan (Teveten), irbesartan (Avapro), and valsartan ... New York Times INDIA'S DISHMAN COMPLETES USFDA INSPECTION FOR … - May 8, 2006 The facility, a 100 per cent Export Oriented Unit, manufactures 'Eprosartan Mesylate', which would be supplied to global major Solvay Pharmaceuticals, BV, ... $4.95 - AsiaPulse News - ECNext Merger and Acquisition Scenario - Mar 11, 2006 Teveten HCT (Eprosartan/Hydrochlorothiazide). Calcium Channel Blocking Agents. Therapeutics that treat high blood pressure by blocking the beta adrenergic ... $250.00 - Revere Reports - Revere Company Profile Report - Dec 16, 2006 Teveten (Eprosartan Mesylate). Angiotensin II Receptor Antagonists/Thiazide Diuretic Agents. Products:. Teveten HCT (Eprosartan/Hydrochlorothiazide) ... $50.00 - Revere Reports - Revere Kos Announces Strategic Commercialization and Research and … - May 3, 2005 Pursuant to the agreements, Kos acquired Teveten (eprosartan mesylate), ... Teveten HCT, launched in 2003, combines eprosartan with a diuretic (HCT), ... $4.95 - Business Wire - ECNext Drug/Medical Device - Dec 16, 2006 Teveten (Eprosartan Mesylate), Hypertension, Upper Respiratory Tract Infections, Rhinitis, ... Teveten HCT (Eprosartan/Hydrochlorothiazide), Hypertension ... $70.00 - Revere Reports - Revere Glochem into formulations, looking for PE funds - Apr 12, 2008 These include Candesartan, Telmesartan, Eprosartan, Manidipine, Bernidipine, Nebivolol etc. The patents for some of these products have already expired and ... Hindu Business Line Dishman to buy Solvay fine chemicals unit - Jul 9, 2007 Dishman currently supplies the API for Eprosartan Mesylate (EM) - a hypertensive drug marketed by Solvay under the brand Teveten - and its intermediates, ... In-PharmaTechnologist.com í?¬ì²œì¤‘문ì?˜ëŒ€ 분당차병ì›? ë‚´ê³¼ - Nov 1, 2006 ...ë˜? 다른 연구는 ARBì?¸ telmisartan ê³¼ eprosartanì?„ 비êµ?í•´ì„œ ì œ2형 당뇨병과 ê³ í˜ˆì•• ì—?ì„œ ê·¸ ì—í• ì?„ 보았ì?„ ë•Œ ì?¸ìŠ?린과 당, ê·¸ë¦¬ê³ ì¤‘ì„±ì§€ë°©ì?„ 비êµ?í•´ 보았는ë?° 중성 ... 메디í?¬ë‰´ìŠ¤ Potential Metabolic Effects of Micardis (Telmisartan) - Sep 13, 2005 ...reported results of a study of 119 patients with type 2 diabetes and mild hypertension that compared the metabolic effects of Micardis and eprosartan. ... Diabetes In Control Consolidation gains - Jun 8, 2007 It will manufacture Eprosartan Mesylate (API) for being supplied to Solvay and the annual capacity would go up from 60 tonnes to 200 tonnes, adding further ... Daily News & Analysis Bombay Stocks Edge Higher - May 5, 2006 The company has completed US FDA inspection for one of its facility to make Eprosartan Mesylate, an anti hyper-tension drug, to be supplied to Solvay ... TheStreet.com - TheStreet.com (subscription) Fenofibrate is Solvay Pharmaceuticals Flagship Product and Principal ... - Jan 12, 2007 ...(dronabinol) and Serc (betahistine); the influenza vaccine, Influvac; the pancreatic enzyme, Creon; and Teveten (eprosartan mesylate) for hypertension. ... Free with registration - M2 Presswire - AccessMyLibrary.com Kos Reports 49% Increase in Revenue to $179.4 Million, Earnings Per … - Aug 4, 2005 In May 2005, the Company acquired from Biovail Corporation's affiliates an exclusive license to Teveten (eprosartan mesylate) and Teveten HCT (eprosartan ... $4.95 - Business Wire - ECNext Factiva Search - Apr 12, 2005 Hypoglycemia; Eprosartan does not inhibit sympathetic reactivity in humans ... 2005 APR 12 - (NewsRx.com) -- Eprosartan (EPRO), an AT(I)-receptor blocker, ... Pay-Per-View - Science Letter - Factiva, from Dow Jones Kansas Regulations - 129-5-1. Prior authorization. - Nov 3, 2005 ...and (B) zonegran; (4) angiotensin II receptor antagonists: (A) Candesartan: (B) candesartan-HCTZ; (C) eprosartan; (D) eprosartan-HCTZ; (E) olmesartan; ... Pay-Per-View - Kansas Regulations - Loislaw PRoFESS published: Perseverance may pay with telmisartan in recurrent... - Aug 28, 2008 ...such as MOSES (Morbidity and Mortality After Stroke, Eprosartan Compared With Nitrendipine for Secondary Prevention) and HOPE (Heart Outcomes Prevention ... Medwire (subscription) 抗高血压è?¯ç‰©å¸‚场预测 - Jan 25, 2007 ...çš„olmesartan，以å?Šè´?æž—æ ¼å°”Â·å› æ ¼æµ·å§†ï¼?è‘›å…°ç´ Â·å…‹å…¬å?¸çš„替米沙 å?¦ï¼ˆMicardis，telmisartan），和Solvayå…¬å?¸çš„普沙å?¦ï¼ˆTeveten，eprosartan）将连ç»åœ¨ 新市场上市。 ... 金èž?ç•Œ Secondary Stroke Prevention: Recent Advances - Feb 11, 2007 ...ischemia were treated either with the angiotensin receptor blocker eprosartan or the calcium antagonist nitrendipin over a mean period of 2.5 years. ... Deutsches Ärzteblatt Federal Register 2008 - 73 FR 51829 Publication of Guidances for … - Sep 5, 2008 ...multiple RLDs) (24) Divalproex Sodium (25) Doxycycline (multiple dosage forms) (26) Eprosartan Mesylate; Hydrochlorothiazide (27) Esterified Estrogens ... Pay-Per-View - Federal Register 2008 - Loislaw Force of blood - Nov 12, 2006 Currently, there are seven angiotensin II receptor antagonists: valsartan, candesartan, eprosartan, irbesartan, losartan potassium, olmesartan, ... Malaysia Star High Blood Pressure Control is Equal with Common Medications - Nov 2, 2007 The ARBs included were candesartan cilexetil (Atacand), eprosartan (Teveten), irbesartan (Avapro), losartan (Cozaar), olmesartan medoxomil (Benicar), ... SeniorJournal.com 22 nuove autorizzazioni dall'Agenzia del farmaco - Nov 17, 2005 Tra questi ci sono 16 equivalenti-generici e 2 nuovi farmaci, l'ossicodone cloridrato e l'eprosartan+idroclortiazide. In particolare, l'ossicodone ... Pharma Marketing Angiotensin II receptor blockers (ARBs) for high blood pressure - Apr 24, 2007 ...side effects (such as a cough) associated with ACE inhibitors. 1. Eprosartan mesylate (Teveten) is a recently approved ARB that is combined with a diuretic. MSN Health & Fitness Effekt og sikkerhet av angiotensin reseptorblokkere med og uten... - Nov 10, 2008 Det finnes i dag sju ulike ARB tilgjengelig i Norge; losartan, eprosartan, valsartan, irbesartan, kandesartan, telmisartan og olmesartan. ... Nasjonalt kunnskapssenter for helsetjene... Solvay's sourcing from Dishman to cross Rs 100 cr. | Article from … - Oct 23, 2006 Already, Solvay has increased sourcing of eprosartan, an API used in making anti-hypertensive drug Teveten, by 50 percent after their US foray. ... Pay-Per-View - Economic Times - HighBeam Research Sekundärprävention des Schlaganfalls: Was ist neu? Ungereimtheiten - Feb 15, 2008 Trotzdem kam es in der Studie unter Eprosartan numerisch zu mehr Todesfällen. Zudem wurde Nitrendipin in der Studie unterdosiert. ... Deutsches Ärzteblatt Angiotensin II receptor blockers (ARBs).(Cardiology Advisor 2007)(Drug... - May 31, 2007 Candesartan (Atacand), eprosartan (Teveten), irbesartan (Avapro), losartan (Cozaar), olmesartan (Benicar), telmisartan (Micardis), and valsartan (Diovan) ... $4.95 - Clinical Reference Systems - ECNext Press Release: Fenofibrate is Solvay Pharmaceuticals Flagship Product... - Jan 12, 2007 ...(dronabinol) and Serc (betahistine); the influenza vaccine, Influvac; the pancreatic enzyme, Creon; and Teveten (eprosartan mesylate) for hypertension. ... Pay-Per-View - M2 Presswire - HighBeam Research How to take Diflunisal from Consumer Reports Health. - Jan 1, 2006 ...angiotensin II receptor antagonists such as candesartan (Atacand), eprosartan (Teveten), irbesartan (Avapro), losartan (Cozaar), olmesartan (Benicar), ... consumerreports.org Sartani vs ACEi e rischio di IMA - Dec 24, 2007 I Sartani usati erano 5, losartan (9 studi), candesartan (3 studi), valsartan (3 studi), irbesartan (1 studio) e eprosartan (1 studio). ... Pillole.org ReNeuron Group plc - AGM Statement. - Sep 21, 2006 MOSES (Morbidity and mortality after stroke - Eprosartan vs nitrendipine for secondary prevention) study, Feb 2006 2. American Heart Association, Reporting ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com Solvay and Pronova Biocare sign license agreement for Omacor® to … - Sep 26, 2005 OMACOR® is part of the Solvay Pharmaceuticals' cardiology product portfolio, which also includes the anti-hypertensives, TEVETEN® (eprosartan), ... npicenter.com ARBs vs. ACE Inhibitors in Patients with Cardiac Disease - Sep 1, 2005 The studies used the following ARBs: losartan (Cozaar; n = 9), candesartan (Atacand; n = 7), valsartan (Diovan; n = 5), eprosartan (Teveten; n = 1), ... AAFP News Now BRIEFING - ASIA HEALTH - MAY 8, 2006. - May 8, 2006 The facility, a 100 per cent Export Oriented Unit, manufactures 'Eprosartan Mesylate', which would be supplied to global major Solvay Pharmaceuticals, BV, ... Free with registration - AsiaPulse News - AccessMyLibrary.com Rising players in global fine chemicals: Select large custom … - Jul 1, 2006 In May, the Bavla facility successfully completed an FDA inspection for manufacturing the antihypertensive drug eprosartan mesylate for Solvay ... Free with registration - Pharmaceutical Technology - AccessMyLibrary.com Protecting Your Kidneys - Aug 4, 2006 ARBs include candesartan (Atacand), irbesartan (Avapro), olmesartan (Benicar), losartan (Cozaar), valsartan (Diovan), telmisartan (Micardis), and eprosartan ... Diabetes Self Management Abstract and Introduction - Apr 29, 2005 Eprosartan (Teveten) and candesartan (Atacand) also can be dosed once or twice daily, but dos-ing decisions are up to physicians, who base such decisions on ... Medscape Why Solvay dumped Dishman Pharma? - Feb 7, 2006 Some of the big drugs that Solvay sources from Dishman includes vitamin D3 intermediates, along with Eprosartan, which is a cardiac drug. ... Moneycontrol.com Dishman successfully completes US FDA inspection - May 5, 2006 ...to manufacture Eprosartan Mesylate, an anti hyper-tension drug, to be supplied to Solvay Pharmaceuticals, BV, a fortune 500 company. ... Moneycontrol.com ReNeuron Group plc - Exercise of Warrants. - Nov 15, 2006 MOSES (Morbidity and mortality after stroke - Eprosartan vs nitrendipine for secondary prevention) study, Feb 2006 2. American Heart Association, Reporting ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com Eplerenone (Systemic). - Oct 27, 2005 ...trandolapril [eg, Mavik]) or Angiotensin II receptor antagonists (Candesartan [eg, Atacand], eprosartan [eg, Teveten], irbesartan [eg, Avapro, Avalide], ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Indian Pharma turns spotlight on R&D: FICCI - Sep 8, 2005 Dishman Pharmaceuticals' deal with Solvay Pharmaceuticals for supplying eprosartan mesylate, IPCA Labs deal with Merck for bulk drugs and with Tillomed ... pharmabiz.com Effects of losartan and irbesartan on serum uric acid in hypertensive... - Mar 9, 2005 Puig JG, Mateos F, Buno A, Ortega R, Rodriguez F, Dal Re R. Effect of eprosartan and losartan on uric acid metabolism in patients with essential ... Nature.com Angiotensin II receptor blockers (ARB).(Cardiology Advisor 2006)(Drug... - Nov 1, 2006 Candesartan (Atacand), eprosartan (Teveten), irbesartan (Avapro), losartan (Cozaar), olmesartan (Benicar), telmisartan (Micardis), and valsartan (Diovan) ... $4.95 - Clinical Reference Systems - ECNext Angiotensin II receptor blockers (ARB).(Drug overview) - May 24, 2006 Candesartan (Atacand), eprosartan (Teveten), irbesartan (Avapro), losartan (Cozaar), olmesartan (Benicar), telmisartan (Micardis), and valsartan (Diovan) ... $4.95 - Clinical Reference Systems - ECNext Merger and Acquisition Scenario - Mar 11, 2006 Teveten SB (Super-Bioavailable Eprosartan); Carvedilol SB (Super-Bioavailable Carvedilol); Enalapril XL. Vascular Disorders. Hypertension ... $250.00 - Revere Reports - Revere Heart failure patients to benefit as PBS restriction lifted - Mar 30, 2005 Candesartan (Atacand), eprosartan (Teveten), irbesartan (Avapro, Karvea) and telmisartan (Micardis) will be listed as unrestricted from 1 April, ... Pay-Per-View - Australian Doctor - Factiva, from Dow Jones Product Licensing; License, supply agreement signed for product for … - Oct 27, 2005 Omacor is part of the Solvay Pharmaceuticals' cardiology product portfolio, which also includes the anti-hypertensives, Teveten (eprosartan), ... Pay-Per-View - Blood Weekly - Factiva, from Dow Jones Product Licensing; License, supply agreement signed for product for … - Oct 30, 2005 Omacor is part of the Solvay Pharmaceuticals' cardiology product portfolio, which also includes the anti-hypertensives, Teveten (eprosartan), ... Pay-Per-View - Heart Disease Weekly - Factiva, from Dow Jones Factiva Search - Jan 3, 2005 2005 JAN 3 - (NewsRx.com & NewsRx.net) -- Moxonidine normalizes sympathetic hyperactivity in patients with eprosartan-treated ... ... Pay-Per-View - Gastroenterology Week - Factiva, from Dow Jones Merger and Acquisition Scenario - Mar 9, 2006 Teveten SB (Super-Bioavailable Eprosartan); Carvedilol SB (Super-Bioavailable Carvedilol); Enalapril XL. Vascular Disorders. Hypertension ... $250.00 - Revere Reports - Revere Article: Pregnancy problems may portend future stroke.(Clinical... - Mar 1, 2006 September 27, 2004 ; 700+ words ...2004 SEP 27 - (NewsRx.com & NewsRx.net) -- The established antihypertensive agent Teveten (eprosartan) has now been ... Pay-Per-View - OB GYN News - HighBeam Research Impaired basal NO activity in patients with glomerular disease and... - Aug 2, 2006 Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension. Kidney Int 2002; 61: 1545–1547. ... Nature.com Ist Blutdrucksenkung gleich Blutdrucksenkung? - Aug 23, 2005 Aber auch andere Studien, etwa die MOSES-Studie, in der die Behandlung mit Eprosartan die Schlaganfallrate in der Sekundärprävention besser gesenkt hat als ... Ärzte Zeitung Tedavi Yardımına (ilaç) iliÅŸkin Maliye Bakanlığı Genelgesi - Jun 14, 2006 Sistemik Antimikrobik ve DiÄŸer Ä°laçların Reçeteleme Kuralları Listesinin (Ek-2/A) 149 uncu sırasına “Eprosartan Mesilatâ€? etken maddesi ilave edilmiÅŸtir. ... Memurlar 아서틸 중심으로 본 ASCOT-BPLA - Mar 30, 2006 ...셋째로 뉴 드러그 중 ì–´ë–¤ 것ì?´ 좋ì?€ê°€ì—? 대해서는MOSES(Morbidity and mortality after Stroke Eprosartan vs nitrendipine for Secondary prevention) 연구ì—?ì„œ ... 메디칼트리뷴 DHL 2006: Aussagekraft der Langzeitblutdruckmessung gegenüber der … - Nov 27, 2006 Im Unterschied zu Losartan und Eprosartan bindet Telmisartan an den gleichen Zellkernrezeptor (PPARgamma) wie die blutzuckersenkenden Glitazone. ... journalmed.de Hoge bloeddruk - Nov 15, 2005 Voorbeelden zijn candesartan, eprosartan, irbesartan, losartan, telmisartan en valsartan. Calciumblokkers verlagen de spanning in de spiertjes rond de ... kiesbeter.nl Substantial progress has been made in treatments for organ-specific … - Oct 1, 2007 Eprosartan Erythromycin Esomeprazole Famotidine Felodipine Fluvastatin Irbesartan Isradipine Lansoprazole Losartan Lovastatin Metoclopramide Metronidazole ... $4.95 - Journal of Musculoskeletal Medicine - ECNext Georgia Code - 16-13-71. (a) A "dangerous drug" means any drug other ... - Aug 4, 2005 ...(334.4) Eplerenone; (334.5) Epoprostenol; (334.7) Eprosartan; (334.8) Eptifibatide; (335) Ergocalciferol — See exceptions; (335.5) Ergoloid mesylates; ... Pay-Per-View - Georgia Code - Loislaw |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |